Bruckmueller H - Search Results

1

Identification and characterization of a defective CYP3A4 genotype in a kidney transplant patient with severely diminished tacrolimus clearance.

Werk AN, Lefeldt S, Bruckmueller H, Hemmrich-Stanisak G, Franke A, Roos M, Küchle C, Steubl D, Schmaderer C, Bräsen JH, Heemann U, Cascorbi I, Renders L. Werk AN, et al. Among authors: bruckmueller h. Clin Pharmacol Ther. 2014 Apr;95(4):416-22. doi: 10.1038/clpt.2013.210. Epub 2013 Oct 14. Clin Pharmacol Ther. 2014. PMID: 24126681

2

Which Genetic Determinants Should be Considered for Tacrolimus Dose Optimization in Kidney Transplantation? A Combined Analysis of Genes Affecting the CYP3A Locus.

Bruckmueller H, Werk AN, Renders L, Feldkamp T, Tepel M, Borst C, Caliebe A, Kunzendorf U, Cascorbi I. Bruckmueller H, et al. Ther Drug Monit. 2015 Jun;37(3):288-95. doi: 10.1097/FTD.0000000000000142. Ther Drug Monit. 2015. PMID: 25271728

3

Genetic variants may play an important role in mRNA-miRNA interaction: evidence for haplotype-dependent downregulation of ABCC2 (MRP2) by miRNA-379.

Werk AN, Bruckmueller H, Haenisch S, Cascorbi I. Werk AN, et al. Among authors: bruckmueller h. Pharmacogenet Genomics. 2014 Jun;24(6):283-91. doi: 10.1097/FPC.0000000000000046. Pharmacogenet Genomics. 2014. PMID: 24743544

4

Drug-Drug-Gene Interactions: A Call for Clinical Consideration.

Bruckmueller H, Cascorbi I. Bruckmueller H, et al. Clin Pharmacol Ther. 2021 Sep;110(3):549-551. doi: 10.1002/cpt.2348. Epub 2021 Jul 18. Clin Pharmacol Ther. 2021. PMID: 34278570 No abstract available.

5

Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379.

Haenisch S, Laechelt S, Bruckmueller H, Werk A, Noack A, Bruhn O, Remmler C, Cascorbi I. Haenisch S, et al. Among authors: bruckmueller h. Mol Pharmacol. 2011 Aug;80(2):314-20. doi: 10.1124/mol.110.070714. Epub 2011 May 3. Mol Pharmacol. 2011. PMID: 21540293

6

ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?

Bruckmueller H, Cascorbi I. Bruckmueller H, et al. Expert Opin Drug Metab Toxicol. 2021 Apr;17(4):369-396. doi: 10.1080/17425255.2021.1876661. Epub 2021 Feb 2. Expert Opin Drug Metab Toxicol. 2021. PMID: 33459081 Review.

7

Implications of genetic variation of common Drug Metabolizing Enzymes and ABC Transporters among the Pakistani Population.

Afsar NA, Bruckmueller H, Werk AN, Nisar MK, Ahmad HR, Cascorbi I. Afsar NA, et al. Among authors: bruckmueller h. Sci Rep. 2019 May 13;9(1):7323. doi: 10.1038/s41598-019-43736-z. Sci Rep. 2019. PMID: 31086207 Free PMC article.

8

Interaction of herbal products with prescribed medications: A systematic review and meta-analysis.

Awortwe C, Bruckmueller H, Cascorbi I. Awortwe C, et al. Among authors: bruckmueller h. Pharmacol Res. 2019 Mar;141:397-408. doi: 10.1016/j.phrs.2019.01.028. Epub 2019 Jan 17. Pharmacol Res. 2019. PMID: 30660822

9

Interaction of Phytocompounds of Echinacea purpurea with ABCB1 and ABCG2 Efflux Transporters.

Awortwe C, Bruckmueller H, Kaehler M, Cascorbi I. Awortwe C, et al. Among authors: bruckmueller h. Mol Pharm. 2021 Apr 5;18(4):1622-1633. doi: 10.1021/acs.molpharmaceut.0c01075. Epub 2021 Mar 17. Mol Pharm. 2021. PMID: 33730506

10

MicroRNA-655-3p regulates Echinacea purpurea mediated activation of ABCG2.

Awortwe C, Kaehler M, Rosenkranz B, Cascorbi I, Bruckmueller H. Awortwe C, et al. Among authors: bruckmueller h. Xenobiotica. 2018 Oct;48(10):1050-1058. doi: 10.1080/00498254.2017.1390624. Epub 2017 Nov 2. Xenobiotica. 2018. PMID: 28990842

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page